ID: ALA3410746

Max Phase: Preclinical

Molecular Formula: C16H15IO4

Molecular Weight: 398.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1cc(C(=O)COc2ccc(I)cc2)c(O)cc1O

Standard InChI:  InChI=1S/C16H15IO4/c1-2-10-7-13(15(19)8-14(10)18)16(20)9-21-12-5-3-11(17)4-6-12/h3-8,18-19H,2,9H2,1H3

Standard InChI Key:  KLCKIIGWTHQDHG-UHFFFAOYSA-N

Associated Targets(Human)

Krueppel-like factor 10 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 398.20Molecular Weight (Monoisotopic): 398.0015AlogP: 3.53#Rotatable Bonds: 5
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.03CX Basic pKa: CX LogP: 4.98CX LogD: 4.89
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.60Np Likeness Score: -0.55

References

1. Khedkar SA, Sun X, Rigby AC, Feinberg MW..  (2015)  Discovery of small molecule inhibitors to Krüppel-like factor 10 (KLF10): implications for modulation of T regulatory cell differentiation.,  58  (3): [PMID:25581017] [10.1021/jm5018187]
2.  (2017)  Use of small molecule inhibitors to klf10 for modulation of t regulatory cells and cancer immunotherapy,